|
|
||||||||||||||
|
|
|||||||||||||||
|
© 2005 BMJ Publishing Group Ltd
A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agentD Wong1, J C Van Meurs2, T Stappler1, C Groenewald1, I A Pearce1, J N McGalliard1,*, E Manousakis1, E N Herbert1
1 St Pauls Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK
Correspondence to:
Methods: 42 consecutive patients were recruited. The indications include proliferative vitreoretinopathy, retinal detachments arising from inferior retinal breaks, and inability to posture. Results: The success rate with one operation using Densiron was 81% and with further surgery 93%. At the end of the study all tamponade agents were removed in 90% of patients. Visual acuity improved from mean logMAR of 1.41 (SD 0.64) to 0.94 (SD 0.57), p = 0.001. There was little evidence of dispersion and excessive inflammation. Conclusion: This new tamponade agent is being compared to conventional silicone oil in a prospective international randomised trial.
Abbreviations: ERM, epiretinal membranes; PFCL, perfluorocarbon liquids; PPV, pars plana vitrectomy; PVR, proliferative vitreoretinopathy; RD, retinal detachments; SiO, silicone oil Keywords: perfluorohexyloctane; silicone oil; proliferative vitreoretinopathy; retinal detachment
Relevant Article
This article has been cited by other articles:
|
||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |